An integrated, multi-stakeholder approach

The multi-stakeholder world is increasingly complex, with shifting dynamics and stakeholder groups engaging in different ways, through different channels, at different times and by different customer-facing functions. Navigating this complex interplay continues to be one of the biggest challenges facing the industry.

Find out more by downloading your free copy today >>>

In this whitepaper, we examine:

  • The influence of three key groups of stakeholders
    – Patients (and their support ecosystems); HCPs and
    Providers; and Payers/ Policy Makers in shaping key
    decision-making within healthcare systems today

  • What leaders at Actelion, Pfizer and Bayer believe a
    multi-stakeholder approach looks like

  • The benefits of aligning your commercial structure
    around multiple stakeholders including consistent and
    cohesive messaging.

Download your copy of the content now >>>

With expert contributions from:

  • Hans Gilhuyus, Global Multi Channel Capabilities Director, GSK
  • Jane Griffiths, Global HeadActelion
  • Markus Kosch, Vice President, Oncology Portfolio, Europe, 
    Japan & Developed Asia
    Pfizer Oncology
  • Sebastian Guth, Executive Vice President and Chief Marketing
    Bayer Pharmaceuticals
  • Barrett Madrigal, Senior Director Eli Lilly Japan KK. Operation 
    Member of Global Bio-Medicines Lead Team
  • Bob Oliver, Chief Executive Officer, VClinBio
  • Kabir Nath, CEO, Otsuka Pharmaceuticals US

Discover how the integrated multi-channel approach will change pharma, download your copy
today >>>

Please let me know if you have any feedback.

Kind regards,

Whitepaper: Balancing payers, patients and physicians

eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.

Terms and conditions | Privacy Policy

Fill in your details below to access this whitepaper